We are live on ! Find out more
AMPE

Ampio Pharmaceuticals Inc.

Delisted

AMPE was delisted on the 12th of April, 2024.

121 hedge funds and large institutions have $72.6M invested in Ampio Pharmaceuticals Inc. in 2021 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 31 increasing their positions, 28 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

728% more call options, than puts

Call options by funds: $1.94M | Put options by funds: $234K

11% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 28

3% less capital invested

Capital invested by funds: $75.2M → $72.6M (-$2.58M)

5% less funds holding

Funds holding: 128121 (-7)

46% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 13

Holders
121
Holders Change
-7
Holders Change %
-5.47%
% of All Funds
2.12%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
31
Reduced
28
Closed
13
Calls
$1.94M
Puts
$234K
Net Calls
+$1.7M
Net Calls Change
-$599K
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$20.4M +$225K +485 +1%
Vanguard Group
2
Vanguard Group
Pennsylvania
$15.4M +$99.7K +215 +0.7%
State Street
3
State Street
Massachusetts
$5.69M +$978K +2,109 +23%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$5.17M +$204K +439 +4%
WIC
5
Willis Investment Counsel
Georgia
$3.37M -$236K -510 -7%
Northern Trust
6
Northern Trust
Illinois
$2.98M -$86.7K -187 -3%
PCMC
7
Private Capital Management (Colorado)
Colorado
$1.56M
BCM
8
Bridgeway Capital Management
Texas
$1.49M -$193K -417 -12%
CFO
9
CVA Family Office
Colorado
$1.12M
AAP
10
Arax Advisory Partners
Colorado
$1.04M
N
11
Nuveen
North Carolina
$986K -$5.56K -12 -0.7%
Bank of New York Mellon
12
Bank of New York Mellon
New York
$884K +$76.5K +165 +10%
Charles Schwab
13
Charles Schwab
California
$825K +$30.6K +66 +4%
D.E. Shaw & Co
14
D.E. Shaw & Co
New York
$695K +$567K +1,223 +711%
CC
15
Courier Capital
New York
$658K
Group One Trading
16
Group One Trading
Illinois
$636K +$51K +110 +9%
BJL
17
Brighton Jones LLC
Washington
$613K +$307K +662 +117%
ACM
18
ACT Capital Management
Pennsylvania
$484K
Susquehanna International Group
19
Susquehanna International Group
Pennsylvania
$399K -$524K -1,131 -59%
RJA
20
Raymond James & Associates
Florida
$357K -$1.85K -4 -0.6%
CCMW
21
Cypress Capital Management (Wyoming)
Wyoming
$327K -$15.3K -33 -5%
Simplex Trading
22
Simplex Trading
Illinois
$259K
RhumbLine Advisers
23
RhumbLine Advisers
Massachusetts
$249K +$13.9K +30 +6%
BIAS
24
Beacon Investment Advisory Services
New Jersey
$241K +$162K +350 +263%
Morgan Stanley
25
Morgan Stanley
New York
$237K +$18.5K +40 +9%

AMPE Hedge Fund Activity: Q3 2021 in Review

121 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q3 2021, worth a combined $72.6M — down 3.4% from $75.2M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of AMPE and 7 opened new positions — a net loss of 6 holders — while 28 trimmed existing stakes and 31 added.

The largest buyer was State Street, adding an estimated $978K. The largest seller was First Trust Advisors, exiting entirely with an estimated $763K sold.

  • 121 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q3 2021, down from 128 in Q2 2021.
  • Funds reported $72.6M of Ampio Pharmaceuticals Inc. stock for Q3 2021, down 3.4% quarter-over-quarter.
  • 7 funds opened new Ampio Pharmaceuticals Inc. positions in Q3 2021 and 13 closed out, a net change of -6 holders.
  • The largest Ampio Pharmaceuticals Inc. buyer in Q3 2021 was State Street, an estimated $978K added.
  • The largest Ampio Pharmaceuticals Inc. seller in Q3 2021 was First Trust Advisors, an estimated $763K sold.

Based on aggregated 13F filings for Q3 2021.